Business Performance Review

EBITDA (In Millions) EBITDA EBITDA Margin Financial Performance Track Record Robust growth and profitability indicators over the years Revenue (In Millions) CAGR 11.4% 21,612 21,232 18,852 15,373 14,050 PAT (In Millions) PAT EPS (In) 4,670 4,187 31.0% PAT Margin 20.8% 20.4% 18.6% 19.7% 21.6% 31.5% 31.4% 29.7% 30.6% 6,308 5,919 6,712 3,516 3,131 2,927 38.1 35.6 32.6 29.0 27.1 Є Glenmark LIFE SCIENCES FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 4,840 4,298 Note: Numbers of FY19 are based on Proforma Financials. 7

View entire presentation